The price of Applied Dna Sciences Inc (NASDAQ: APDN) closed at $0.41 in the last session, down -4.21% from day before closing price of $0.43. In other words, the price has decreased by -$0.0180 from its previous closing price. On the day, 50383 shares were traded.
Ratios:
We take a closer look at APDN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.63 and its Current Ratio is at 1.77. In the meantime, Its Debt-to-Equity ratio is 0.26 whereas as Long-Term Debt/Eq ratio is at 0.14.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH Capital on February 12, 2021, initiated with a Buy rating and assigned the stock a target price of $24.
On January 14, 2021, H.C. Wainwright reiterated its Buy rating and also upped its target price recommendation from $18 to $14.
H.C. Wainwright reiterated its Buy rating for the stock on December 18, 2020, while the target price for the stock was revised from $20 to $12.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APDN now has a Market Capitalization of 7.27M and an Enterprise Value of 5.03M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.77 while its Price-to-Book (P/B) ratio in mrq is 1.32. Its current Enterprise Value per Revenue stands at 0.56 whereas that against EBITDA is -0.41.
Stock Price History:
Over the past 52 weeks, APDN has reached a high of $1.86, while it has fallen to a 52-week low of $0.37. The 50-Day Moving Average of the stock is 0.5654, while the 200-Day Moving Average is calculated to be 0.9785.
Shares Statistics:
According to the various share statistics, APDN traded on average about 107.30K shares per day over the past 3-months and 258.46k shares per day over the past 10 days. A total of 16.98M shares are outstanding, with a floating share count of 14.89M. Insiders hold about 12.32% of the company’s shares, while institutions hold 9.45% stake in the company. Shares short for APDN as of Mar 15, 2024 were 261.21k with a Short Ratio of 2.43, compared to 272.68k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.54% and a Short% of Float of 1.92%.
Earnings Estimates
The company has 2 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.22 for the current quarter, with a high estimate of -$0.22 and a low estimate of -$0.23, while EPS last year was $0.05. The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.17 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$0.63 and -$0.67 for the fiscal current year, implying an average EPS of -$0.65. EPS for the following year is -$0.53, with 2 analysts recommending between -$0.48 and -$0.58.
Revenue Estimates
A total of 2 analysts have provided revenue estimates for APDN’s current fiscal year. The highest revenue estimate was $6.1M, while the lowest revenue estimate was $3.94M, resulting in an average revenue estimate of $5.02M. In the same quarter a year ago, actual revenue was $13.37M, down -62.40% from the average estimate. Based on 2 analysts’ estimates, the company’s revenue will be $8.17M in the next fiscal year. The high estimate is $9.29M and the low estimate is $7.05M. The average revenue growth estimate for next year is up 62.70% from the average revenue estimate for this year.
